Josh Hoffman, outgoing Zymergen CEO (Zymergen)
Synbio unicorn Zymergen jettisons founding CEO, cuts guidance as customers report lead product doesn't work
Zymergen, just months off a $500 million IPO that put the synthetic bio firm in rarified air, has now ejected its founding CEO and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
